Literature DB >> 20560935

Double inverse-weighted estimation of cumulative treatment effects under nonproportional hazards and dependent censoring.

Douglas E Schaubel1, Guanghui Wei.   

Abstract

In medical studies of time-to-event data, nonproportional hazards and dependent censoring are very common issues when estimating the treatment effect. A traditional method for dealing with time-dependent treatment effects is to model the time-dependence parametrically. Limitations of this approach include the difficulty to verify the correctness of the specified functional form and the fact that, in the presence of a treatment effect that varies over time, investigators are usually interested in the cumulative as opposed to instantaneous treatment effect. In many applications, censoring time is not independent of event time. Therefore, we propose methods for estimating the cumulative treatment effect in the presence of nonproportional hazards and dependent censoring. Three measures are proposed, including the ratio of cumulative hazards, relative risk, and difference in restricted mean lifetime. For each measure, we propose a double inverse-weighted estimator, constructed by first using inverse probability of treatment weighting (IPTW) to balance the treatment-specific covariate distributions, then using inverse probability of censoring weighting (IPCW) to overcome the dependent censoring. The proposed estimators are shown to be consistent and asymptotically normal. We study their finite-sample properties through simulation. The proposed methods are used to compare kidney wait-list mortality by race.
© 2010, The International Biometric Society.

Entities:  

Mesh:

Year:  2011        PMID: 20560935      PMCID: PMC3372067          DOI: 10.1111/j.1541-0420.2010.01449.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Causal inference on the difference of the restricted mean lifetime between two groups.

Authors:  P Y Chen; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

2.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

3.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

4.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

5.  Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.

Authors:  Babette A Brumback; Miguel A Hernán; Sebastien J P A Haneuse; James M Robins
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

6.  Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data.

Authors:  Jun Xie; Chaofeng Liu
Journal:  Stat Med       Date:  2005-10-30       Impact factor: 2.373

7.  Bayesian sensitivity analysis for unmeasured confounding in observational studies.

Authors:  Lawrence C McCandless; Paul Gustafson; Adrian Levy
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

8.  Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.

Authors:  Yutaka Matsuyama; Takuhiro Yamaguchi
Journal:  Pharm Stat       Date:  2008 Jul-Sep       Impact factor: 1.894

9.  Sensitivity analysis for unmeasured confounding in a marginal structural Cox proportional hazards model.

Authors:  Ole Klungsøyr; Joe Sexton; Inger Sandanger; Jan F Nygård
Journal:  Lifetime Data Anal       Date:  2008-12-25       Impact factor: 1.588

10.  Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).

Authors:  Mizuki Yoshida; Yutaka Matsuyama; Yasuo Ohashi
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

View more
  20 in total

1.  Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.

Authors:  Pratima Sharma; Xu Shu; Douglas E Schaubel; Randall S Sung; John C Magee
Journal:  Liver Transpl       Date:  2016-01       Impact factor: 5.799

2.  Semiparametric inference on the absolute risk reduction and the restricted mean survival difference.

Authors:  Song Yang
Journal:  Lifetime Data Anal       Date:  2013-02-08       Impact factor: 1.588

3.  Contrasting treatment-specific survival using double-robust estimators.

Authors:  Min Zhang; Douglas E Schaubel
Journal:  Stat Med       Date:  2012-07-16       Impact factor: 2.373

4.  Adjusted restricted mean survival times in observational studies.

Authors:  Sarah C Conner; Lisa M Sullivan; Emelia J Benjamin; Michael P LaValley; Sandro Galea; Ludovic Trinquart
Journal:  Stat Med       Date:  2019-05-22       Impact factor: 2.373

5.  Two-sample tests for survival data from observational studies.

Authors:  Chenxi Li
Journal:  Lifetime Data Anal       Date:  2017-08-28       Impact factor: 1.588

6.  Weighted estimators of the complier average causal effect on restricted mean survival time with observed instrument-outcome confounders.

Authors:  Sai H Dharmarajan; Yun Li; Douglas Lehmann; Douglas E Schaubel
Journal:  Biom J       Date:  2020-12-21       Impact factor: 2.207

7.  Modeling restricted mean survival time under general censoring mechanisms.

Authors:  Xin Wang; Douglas E Schaubel
Journal:  Lifetime Data Anal       Date:  2017-02-21       Impact factor: 1.588

8.  On the restricted mean survival time curve in survival analysis.

Authors:  Lihui Zhao; Brian Claggett; Lu Tian; Hajime Uno; Marc A Pfeffer; Scott D Solomon; Lorenzo Trippa; L J Wei
Journal:  Biometrics       Date:  2015-08-24       Impact factor: 2.571

9.  Estimating restricted mean treatment effects with stacked survival models.

Authors:  Andrew Wey; David M Vock; John Connett; Kyle Rudser
Journal:  Stat Med       Date:  2016-03-02       Impact factor: 2.373

10.  Modeling potential time to event data with competing risks.

Authors:  Liang Li; Bo Hu; Michael W Kattan
Journal:  Lifetime Data Anal       Date:  2013-09-24       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.